R1 RCM (NASDAQ:RCM) Shares Cross Above 200-Day Moving Average – Time to Sell?

R1 RCM Inc. (NASDAQ:RCM)’s share price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $13.25 and traded as high as $14.29. R1 RCM shares last traded at $14.28, with a volume of 1,997,833 shares trading hands.

Analysts Set New Price Targets

Several research analysts recently issued reports on RCM shares. Cantor Fitzgerald reissued a “neutral” rating and issued a $14.30 price objective on shares of R1 RCM in a research note on Friday, October 4th. TD Cowen reaffirmed a “hold” rating and set a $14.30 target price (down previously from $20.00) on shares of R1 RCM in a research report on Monday, August 5th. Deutsche Bank Aktiengesellschaft increased their target price on R1 RCM from $14.00 to $16.00 and gave the company a “hold” rating in a research report on Tuesday, July 9th. Leerink Partners cut R1 RCM from an “outperform” rating to a “market perform” rating and dropped their target price for the company from $17.00 to $14.30 in a research report on Thursday, August 1st. Finally, Canaccord Genuity Group reaffirmed a “buy” rating and set a $15.00 target price on shares of R1 RCM in a research report on Monday, July 22nd. Thirteen analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $15.41.

R1 RCM Price Performance

The stock has a 50 day simple moving average of $14.17 and a two-hundred day simple moving average of $13.25. The firm has a market cap of $6.03 billion, a PE ratio of -142.80 and a beta of 0.84. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.84 and a current ratio of 1.84.

R1 RCM (NASDAQ:RCM) last posted its earnings results on Wednesday, August 7th. The healthcare provider reported ($0.02) EPS for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.03. R1 RCM had a negative return on equity of 1.44% and a negative net margin of 1.68%. The firm had revenue of $627.90 million for the quarter, compared to analysts’ expectations of $633.10 million. The firm’s revenue for the quarter was up 12.0% compared to the same quarter last year. Sell-side analysts expect that R1 RCM Inc. will post -0.37 earnings per share for the current year.

Institutional Investors Weigh In On R1 RCM

A number of institutional investors have recently modified their holdings of the business. GAMMA Investing LLC boosted its holdings in R1 RCM by 41.3% in the 3rd quarter. GAMMA Investing LLC now owns 2,597 shares of the healthcare provider’s stock worth $37,000 after buying an additional 759 shares during the last quarter. Arizona State Retirement System boosted its holdings in R1 RCM by 2.1% in the 2nd quarter. Arizona State Retirement System now owns 47,063 shares of the healthcare provider’s stock worth $591,000 after buying an additional 969 shares during the last quarter. QRG Capital Management Inc. boosted its holdings in R1 RCM by 10.6% in the 2nd quarter. QRG Capital Management Inc. now owns 11,307 shares of the healthcare provider’s stock worth $142,000 after buying an additional 1,080 shares during the last quarter. State of Michigan Retirement System boosted its holdings in R1 RCM by 2.5% in the 1st quarter. State of Michigan Retirement System now owns 48,401 shares of the healthcare provider’s stock worth $623,000 after buying an additional 1,200 shares during the last quarter. Finally, Advisors Asset Management Inc. acquired a new stake in R1 RCM in the 1st quarter worth about $27,000. 61.10% of the stock is currently owned by institutional investors and hedge funds.

R1 RCM Company Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.